Skip to main content
. 2009 Oct 30;115(5):925–935. doi: 10.1182/blood-2009-08-239186

Figure 6.

Figure 6

Overall survival of the 114 patients receiving CTLs. The mean Kaplan-Meier estimate (with 95% confidence levels) at 3, 5, and 10 years was 70% (61%-78%), 69% (60%-77%), and 67% (57%-76%), respectively. Tic marks on the survival curves indicate patients still at risk; dashed lines outline the 95% confidence levels.